Oppenheimer Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.7M | Buy |
597,429
+59,676
| +11% | +$4.81M | 0.49% | 39 |
|
|
2026
Q1 | $46.6M | Buy |
537,753
+18,442
| +4% | +$1.77M | 0.53% | 36 |
|
|
2025
Q4 | $49.9M | Sell |
519,311
-24,907
| -5% | -$2.42M | 0.61% | 31 |
|
|
2025
Q3 | $51.8M | Sell |
544,218
-7,855
| -1% | -$722K | 0.57% | 30 |
|
|
2025
Q2 | $48.1M | Buy |
552,073
+3,004
| +0.5% | +$255K | 0.55% | 32 |
|
|
2025
Q1 | $49.3M | Buy |
549,069
+57,203
| +12% | +$5.12M | 0.61% | 27 |
|
|
2024
Q4 | $39.3M | Sell |
491,866
-52,158
| -10% | -$4.52M | 0.48% | 39 |
|
|
2024
Q3 | $49M | Sell |
544,024
-25,378
| -4% | -$2.13M | 0.59% | 30 |
|
|
2024
Q2 | $44.8M | Buy |
569,402
+74,876
| +15% | +$6.14M | 0.57% | 32 |
|
|
2024
Q1 | $43.1M | Sell |
494,526
-48,593
| -9% | -$4.15M | 0.63% | 32 |
|
|
2023
Q4 | $44.7M | Sell |
543,119
-46,941
| -8% | -$3.58M | 0.62% | 31 |
|
|
2023
Q3 | $46.2M | Buy |
590,060
+36,619
| +7% | +$3.07M | 0.71% | 28 |
|
|
2023
Q2 | $48.8M | Sell |
553,441
-11,028
| -2% | -$949K | 0.72% | 29 |
|
|
2023
Q1 | $45.5M | Buy |
564,469
+70,200
| +14% | +$5.72M | 0.7% | 29 |
|
|
2022
Q4 | $38.4M | Sell |
494,269
-24,589
| -5% | -$1.99M | 0.62% | 32 |
|
|
2022
Q3 | $41.9M | Buy |
518,858
+49,175
| +10% | +$4.42M | 0.74% | 20 |
|
|
2022
Q2 | $42.2M | Buy |
469,683
+43,864
| +10% | +$4.44M | 0.71% | 23 |
|
|
2022
Q1 | $47.2M | Buy |
425,819
+113,938
| +37% | +$12M | 0.67% | 30 |
|
|
2021
Q4 | $32.3M | Buy |
311,881
+8,589
| +3% | +$995K | 0.43% | 45 |
|
|
2021
Q3 | $38M | Buy |
303,292
+27,442
| +10% | +$3.55M | 0.54% | 36 |
|
|
2021
Q2 | $34.2M | Buy |
275,850
+4,202
| +2% | +$528K | 0.49% | 43 |
|
|
2021
Q1 | $32.1M | Buy |
271,648
+5,646
| +2% | +$662K | 0.5% | 39 |
|
|
2020
Q4 | $31.2M | Buy |
266,002
+16,587
| +7% | +$1.83M | 0.52% | 39 |
|
|
2020
Q3 | $25.9M | Buy |
249,415
+63,503
| +34% | +$6.38M | 0.5% | 41 |
|
|
2020
Q2 | $17M | Buy |
185,912
+40,031
| +27% | +$3.84M | 0.35% | 58 |
|
|
2020
Q1 | $13.2M | Buy |
145,881
+112,357
| +335% | +$12M | 0.32% | 74 |
|
|
2019
Q4 | $3.8M | Sell |
33,524
-4,448
| -12% | -$488K | 0.08% | 272 |
|
|
2019
Q3 | $4.12M | Sell |
37,972
-3,617
| -9% | -$377K | 0.09% | 256 |
|
|
2019
Q2 | $4.05M | Sell |
41,589
-18,228
| -30% | -$1.66M | 0.09% | 261 |
|
|
2019
Q1 | $5.45M | Buy |
59,817
+1,954
| +3% | +$175K | 0.12% | 206 |
|
|
2018
Q4 | $5.26M | Buy |
57,863
+5,514
| +11% | +$515K | 0.13% | 187 |
|
|
2018
Q3 | $5.15M | Buy |
52,349
+1,090
| +2% | +$101K | 0.11% | 217 |
|
|
2018
Q2 | $4.39M | Buy |
51,259
+287
| +0.6% | +$24K | 0.11% | 235 |
|
|
2018
Q1 | $4.09M | Buy |
50,972
+29,169
| +134% | +$2.41M | 0.1% | 248 |
|
|
2017
Q4 | $1.7M | Hold |
21,803
| – | – | 0.05% | 419 |
|
|
2017
Q3 | $1.7M | Sell |
21,803
-24,252
| -53% | -$2.01M | 0.04% | 421 |
|
|
2017
Q2 | $4.09M | Sell |
46,055
-12,376
| -21% | -$1.04M | 0.11% | 213 |
|
|
2017
Q1 | $4.71M | Buy |
+58,431
| New | +$4.56M | 0.13% | 179 |
|
Other funds holding MDT
Oppenheimer Asset Management's MDT Position: Q2 2026 in Review
Oppenheimer Asset Management increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $4.81M and bringing the position to 597,429 shares worth $46.7M. The position accounts for 0.49% of the portfolio, ranked #39.
Oppenheimer Asset Management first reported a position in MDT in Q1 2017 and has held it in 38 quarters since. The position peaked at $51.8M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Oppenheimer Asset Management held 597,429 shares of Medtronic worth $46.7M as of Q2 2026.
- Oppenheimer Asset Management bought 59,676 Medtronic shares in Q2 2026, an estimated $4.81M.
- Medtronic made up 0.49% of Oppenheimer Asset Management's portfolio in Q2 2026, its #39 holding.
- Oppenheimer Asset Management first reported a position in Medtronic in Q1 2017 and has held it in 38 quarters since.
- Oppenheimer Asset Management's Medtronic position peaked at $51.8M in Q3 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.